Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Nephrology"
DOI: 10.1159/000516156
Abstract: Introduction: Phosphate binders are used to treat hyperphosphatemia. Some patients have inappropriately controlled serum phosphorus levels, which may occur for many reasons, including a high pill burden and adverse events (AEs). Tenapanor selectively inhibits the… read more here.
Keywords: serum phosphorus; phosphorus levels; phosphorus; add tenapanor ... See more keywords